BAN2401

Biogen, Eisai are pushing for another accelerated Alzheimer's OK — this time for BAN2401
Endpoints
Wed, 08/4/21 - 10:55 am
Biogen
Eisai
FDA
Alzheimer's disease
BAN2401
Biogen Partner Pushing On With Alzheimer’s Drug Despite Fracas
Bloomberg
Thu, 07/15/21 - 10:45 am
Biogen
Eisai
Alzheimer's disease
lecanemab
BAN2401
When Will Lecanemab be Available to Alzheimer’s Patients?
BioSpace
Tue, 04/20/21 - 11:11 pm
Eisai
lecanemab
BAN2401
Alzheimer's disease
Biogen and Eisai trial drug in asymptomatic Alzheimer’s disease
Pharmaforum
Tue, 07/14/20 - 10:31 am
Biogen
Eisai
Alzheimer's disease
amyloid
BAN2401
clinical trials
Alzheimer’s R&D projects sidelined as Biogen’s aducanumab shock shakes researchers to the core of their beliefs
Endpoints
Tue, 05/14/19 - 09:56 am
Alzheimer's disease
drug development
aducanumab
Biogen
Eisai
BAN2401
Merck
Eli Lilly
AstraZeneca
Eisai Continues Alzheimer's Research, Adds 2 Alzheimer's Pros as Execs
BioSpace
Sun, 05/5/19 - 10:36 am
Eisai
Biogen
Alzheimer's disease
R&D
aducanumab
BAN2401
Is a severely damaged Biogen looking to shed its ties to a controversial development partner?
Endpoints
Sat, 03/23/19 - 12:07 pm
Biogen
Eisai
Alzheimer's disease
BAN2401
RIP amyloid beta theory? Nope. Biogen partner launches a new PhIII before aducanumab's corpse turned cold
Endpoints
Fri, 03/22/19 - 11:58 am
Biogen
Eisai
BAN2401
Alzheimer's disease
clinical trials
Biogen’s ‘positive’ Alzheimer’s trial has a problem with small numbers
Stat
Thu, 10/25/18 - 11:31 am
Biogen
Eisai
BAN2401
Alzheimer's disease
Why Biogen's Stock Ripped Higher in July
Motley Fool
Mon, 08/13/18 - 09:41 am
Biogen
Eisai
BAN2401
Alzheimer's disease
Spinraza
Ionis Pharmaceuticals
Biogen’s high-stakes Alzheimer’s gamble is being roasted by the experts. Is the amyloid beta theory dead?
Endpoints
Thu, 08/9/18 - 09:16 am
Biogen
Eisai
BAN2401
Alzheimer's disease
FOCUS-Eisai/Biogen to advance Alzheimer's drug, provide fresh hope
Yahoo/Reuters
Sun, 08/5/18 - 12:22 pm
Biogen
Eisai
Alzheimer's disease
BAN2401
Why the Latest Alzheimer’s Drug Study Has So Many People Confused
Fortune
Mon, 07/30/18 - 11:55 pm
Biogen
Eisai
BAN2401
clinical trials
Alzheimer's disease
Eisai, Biogen outline a 30% and 47% advantage for their Alzheimer’s drug BAN2401 — but critics drag stock down
Endpoints
Wed, 07/25/18 - 05:11 pm
Biogen
Eisai
Alzheimer's disease
BAN2401
clinical trials
Biogen wants you to know it's more than BAN2401
Biopharma Dive
Tue, 07/24/18 - 11:36 pm
Biogen
BAN2401
As Eisai, Biogen plot a course to accelerated approvals for Alzheimer’s drug, a mob of skeptics are waiting to decipher hard numbers
Endpoints
Tue, 07/24/18 - 11:30 am
Eisai
Biogen
Alzheimer's disease
BAN2401
AAIC
AAIC event – Biogen and Eisai move to consolidate beta-amyloid lead
EP Vantage
Tue, 07/17/18 - 11:20 pm
Biogen
Eisai
BAN2401
Alzheimer's disease
Are We on the Cusp of a Big Alzheimer's Disease Breakthrough?
Motley Fool
Sat, 07/14/18 - 01:21 pm
Alzheimer's disease
clinical trials
Biogen
drug development
BAN2401
The Biogen Bump Bodes Well for Biotech
Barron's
Sat, 07/7/18 - 04:32 pm
Biogen
Eisai
Alzheimer's disease
BAN2401
Biogen reports positive results with Alzheimer’s drug, reviving hopes for once-failed treatment
Stat
Thu, 07/5/18 - 08:24 pm
BAN2401
Biogen
clinical trials
Alzheimer's disease

Pages